Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
2011 1
2013 1
2018 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Ado-trastuzumab emtansine associated spider telangiectasia.
Gursoy P, Acar A, Acikalin T. Gursoy P, et al. J Oncol Pharm Pract. 2022 Jun;28(4):986-988. doi: 10.1177/10781552211073878. Epub 2022 Jan 18. J Oncol Pharm Pract. 2022. PMID: 35040682
CASE REPORT: In our case, we reported our patient who developed mucosal and cutaneous telangiectasia after T-DM1 treatment and who had a complete response in metastases after skin lesions. ...
CASE REPORT: In our case, we reported our patient who developed mucosal and cutaneous telangiectasia after T-DM1 treatment and …
Cutaneous collagenous vasculopathy: development after coronary artery bypass surgery.
Rahnama-Moghadam S, Burgin C, Gilbert J, Warren S. Rahnama-Moghadam S, et al. Dermatol Online J. 2018 May 15;24(5):13030/qt0k8258qw. Dermatol Online J. 2018. PMID: 30142740 Free article.
Clinically, it is characterized by widespread, asymptomatic development of cutaneous telangiectasia in the absence of systemic symptoms. Morphologically, it most resembles generalized essential telangiectasia and other telangiectatic syndromes such as telangiectasia …
Clinically, it is characterized by widespread, asymptomatic development of cutaneous telangiectasia in the absence of systemic …
Cutaneous telangiectasia and cauda equina syndrome: a presentation of diffuse large B-cell lymphoma.
Shim TN, El-Daly H, Carr RA, Taibjee SM, Gach JE. Shim TN, et al. Am J Dermatopathol. 2013 Jun;35(4):507-10. doi: 10.1097/DAD.0b013e31827bcc29. Am J Dermatopathol. 2013. PMID: 23694826
Diffuse large B-cell lymphoma (DLBCL) was confirmed on skin biopsies from plaques on the abdominal wall and left ankle, the possibilities including primary cutaneous DLBCL leg-type or systemic DLBCL. We speculate that this clinical appearance may arise due to lymphatic or …
Diffuse large B-cell lymphoma (DLBCL) was confirmed on skin biopsies from plaques on the abdominal wall and left ankle, the possibilities in …
Therapy for essential cutaneous telangiectasia.
Alderman DB. Alderman DB. Postgrad Med. 1977 Jan;61(1):91-5. doi: 10.1080/00325481.1977.11714509. Postgrad Med. 1977. PMID: 834688
A method of treatment of essential cutaneous telangiectasia is described which has been used successfully in more than 150 cases. ...
A method of treatment of essential cutaneous telangiectasia is described which has been used successfully in more than 150 cas …
Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide.
Alam MA, Sami S, Babu S. Alam MA, et al. BMJ Case Rep. 2011 Nov 8;2011:bcr0820114585. doi: 10.1136/bcr.08.2011.4585. BMJ Case Rep. 2011. PMID: 22674103 Free PMC article.
Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterised by epistaxis, cutaneous telangiectasia and visceral arterio-venous malformations (AVMs). ...
Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterised by epistaxis, cutaneous telangiectasi …